Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Oragenics, Inc. (OGEN) had Cash Flow from Financial Activities of $0.25M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-2.60M |
|
-- |
|
-- |
|
$2.60M |
|
$-2.60M |
|
$-0.03M |
|
$-2.62M |
|
$-2.62M |
|
$-2.60M |
|
$-2.60M |
|
$-2.60M |
|
$-2.60M |
|
$-2.60M |
|
$-2.60M |
|
4.51M |
|
4.51M |
|
$-0.58 |
|
$-0.58 |
|
| Balance Sheet Financials | |
$3.28M |
|
-- |
|
-- |
|
$3.28M |
|
$2.19M |
|
-- |
|
-- |
|
$2.19M |
|
$1.09M |
|
$1.09M |
|
$1.09M |
|
4.51M |
|
| Cash Flow Statement Financials | |
$-6.42M |
|
$4.00M |
|
|
Cash Flow from Financial Activities |
$0.25M |
$4.40M |
|
$2.23M |
|
$-2.17M |
|
$0.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.50 |
|
-- |
|
-- |
|
-- |
|
0.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-238.29% |
|
-238.30% |
|
-79.33% |
|
-238.30% |
|
$0.24 |
|
$-1.42 |
|
$-1.42 |
|